title: Regulation of hepatic growth hormone receptors in coho salmon (Oncorhynchus kisutch).
abstract: Factors potentially regulating hepatic growth hormone (GH) receptors in coho salmon (Oncorhynchus kisutch) have been investigated. From December to June of the first year, relative changes in hepatic 125I-sGH binding and 35SO4 incorporation by ceratobranchial cartilage were similar. Stunted salmon, which in seawater have elevated plasma GH yet fail to grow, showed lower hepatic 125I-sGH binding than did normally growing seawater salmon. However, MgCl2 treatment of stunts' membranes to reveal total specific binding of 125I-sGH indicated receptor occupation by endogenous sGH. Total specific 125I-sGH binding was low in seawater stunts and remained low if these fish remained unfed after return to fresh water, but increased approximately twofold upon feeding. Total specific binding in fasted salmon in fresh water showed a trend toward decreased levels by 1 week; by 3 weeks, binding was 40% lower than in fed fish. There was a positive correlation (r = 0.600) between condition factor and total specific binding in fed and fasted salmon in fresh water. Two weeks after hypophysectomy total specific binding was 50% lower than in sham-operated control salmon, indicating pituitary regulation of GH receptors. GH treatment reduced both free and total 125I-sGH binding in salmon examined 24 hr after treatment. Treatment with recombinant bovine insulin-like growth factor I, thyroxine, or cortisol did not affect free 125I-sGH binding. Both the pituitary and nutrition appear to be prime regulators of hepatic GH receptors in coho salmon.
authors.affiliation: Department of Integrative Biology, University of California, Berkeley 94720.
authors.forename: E S
authors.initials: ES
authors.lastname: Gray
authors.forename: K M
authors.initials: KM
authors.lastname: Kelley
authors.forename: S
authors.initials: S
authors.lastname: Law
authors.forename: R
authors.initials: R
authors.lastname: Tsai
authors.forename: G
authors.initials: G
authors.lastname: Young
authors.forename: H A
authors.initials: HA
authors.lastname: Bern
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D001827:Body Height; D005215:Fasting / Q000009:adverse effects; D013006:Growth Hormone / Q000502:physiology; D006854:Hydrocortisone / Q000502:physiology; D007334:Insulin-Like Growth Factor I / Q000502:physiology; D008099:Liver / Q000378:metabolism*; D015636:Magnesium Chloride / Q000494:pharmacology; D011986:Receptors, Somatotropin / Q000096:biosynthesis*; D012044:Regression Analysis; D012474:Salmon / Q000502:physiology*; D000254:Sodium-Potassium-Exchanging ATPase / Q000096:biosynthesis; D013974:Thyroxine / Q000502:physiology; D015430:Weight Gain
chemical_list: D001786:Blood Glucose; D011986:Receptors, Somatotropin; D015636:Magnesium Chloride; D007334:Insulin-Like Growth Factor I; D013006:Growth Hormone; D000254:Sodium-Potassium-Exchanging ATPase; D013974:Thyroxine; D006854:Hydrocortisone